Kezar Life Sciences Inc
General ticker "KZR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $507.7M
Kezar Life Sciences Inc follows the US Stock Market performance with the rate: 12.6%.
Estimated limits based on current volatility of 2.6%: low 6.27$, high 6.60$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.46$, 13.47$]
- 2024-12-30 to 2025-12-30 estimated range: [3.96$, 10.79$]
Financial Metrics affecting the KZR estimates:
- Negative: Non-GAAP EPS, $ of -13.20 <= 0.10
- Negative: Operating profit margin, % of -93.76 <= 1.03
- Negative: Operating cash flow per share per price, % of -11.66 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term KZR quotes
Long-term KZR plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $7.00MM |
Operating Expenses | $54.66MM | $71.16MM | $112.24MM |
Operating Income | $-54.66MM | $-71.16MM | $-105.24MM |
Non-Operating Income | $0.03MM | $2.92MM | $3.37MM |
Interest Expense | $0.16MM | $1.19MM | $1.55MM |
R&D Expense | $38.94MM | $51.01MM | $85.70MM |
Income(Loss) | $-54.63MM | $-68.24MM | $-101.87MM |
Profit(Loss) | $-54.63MM | $-68.24MM | $-101.87MM |
Stockholders Equity | $196.88MM | $269.87MM | $187.57MM |
Inventory | $2.50MM | $0.00MM | $0.00MM |
Assets | $217.93MM | $299.57MM | $221.24MM |
Operating Cash Flow | $-42.44MM | $-58.85MM | $-81.64MM |
Capital expenditure | $0.32MM | $1.58MM | $1.81MM |
Investing Cash Flow | $-28.44MM | $-91.39MM | $76.05MM |
Financing Cash Flow | $112.58MM | $127.86MM | $0.64MM |
Earnings Per Share* | $-1.01 | $-0.97 | $-1.40 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.